Bangmao Wang
Tianjin Medical University General Hospital
- Papers in database
- 9
- Years active
- 2019 – 2025
- Total publications
- 266
- Total citations
- 5,719
- h-index
- 39
- Health outcomes studied
- 1
Research Areas
- Gut microbiota and health
- Liver Diseases and Immunity
- Liver Disease Diagnosis and Treatment
- Helicobacter pylori-related gastroenterology studies
- Gastric Cancer Management and Outcomes
Health Outcomes Studied
Papers (9)
- 2025Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.10.1016/s2468-1253(25)00198-0
- 2025Studies on the alleviating effect of <i>Bifidobacterium lactis</i> V9 on dextran sodium sulfate-induced colitis in mice.10.3389/fmed.2025.1496023
- 2022Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.10.3389/fimmu.2022.974305
- 2022Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer?10.1016/j.phrs.2021.106022
- 2022Lactobacillus rhamnosus GG supernatant promotes intestinal mucin production through regulating 5-HT4R and gut microbiota.10.1039/d2fo01900k
- 2021Gut Microbiota in NSAID Enteropathy: New Insights From Inside.10.3389/fcimb.2021.679396
- 2020Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota.10.1016/j.canlet.2019.11.019
- 2020Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells10.3389/fimmu.2020.569104
- 2019The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome.10.3389/fmicb.2019.01894